|Articles|February 11, 2018
Diabetes Organ Damage Highlights AJPB Week in Review
Author(s)AJPB staff
Top articles of the week from The American Journal of Pharmacy Benefits.
Advertisement
5. HHS Secretary Discusses Flu Pandemic with Government Officials
The 2017/2018 influenza season is the worst in recent history.
4. Genetic Analysis for Cardiovascular Disease Could Improve Treatments
New diagnosis methods of patients with cardiovascular disease could lead to more personalized treatment.
3. Oral Drug Shows Promise Reducing Migraine Pain
Ubrogepant had a more significant reduction of pain and migraine-associated symptoms within 2 hours of the initial dose than placebo.
2. NIH Launches Gene Editing Research Program
The National Institutes of Health will fund research on somatic cell genome editing to provide safe and effective treatments in the future.
1. Link Between Heart, Eye Damage in Type 1 Diabetes Discovered
The mechanisms of blood vessel damage from diabetes may affect damage to the heart and eyes.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Operationalizing Epcoritamab-GemOx in Practice: A Focus on EPCORE NHL-2
2
Under Pressure: A Brief Overview of the Updated Hypertension Guidelines
3
Biosimilar Stivant Shows Noninferior Efficacy and Comparable Safety to Reference Bevacizumab
4
Current and Emerging BCMAxCD3 Bispecifics
5
